LABB

Genomma Lab Internacional S.A.B. de C.V

LABB.MX genommalab.com
12.64
-0.11 (-0.86%)
MXN · MX
52-week range
12.60
20.16
Trading at 1% of the 52-week range
Market Cap
12.47B
P/E Ratio
7.68
Forward P/E
6.37
Book Value
12.08
Div. Yield
3.09%
% Institutions
33.62%
% Insiders
31.05%

1 Year

-37.8%

3 Year

+1.0%

10 Year

-21.4%
Description

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and improvement products, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, infant nutrition, and others. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.

Company Information

Company Name
Genomma Lab Internacional S.A.B. de C.V
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
MX
ISIN: MX01LA010006
Currency: MXN
Full Time Employees: 1,658
Phone: 52 55 5081 0000
Fiscal Year End: December
Description:

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and improvement products, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, infant nutrition, and others. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.

Address:

Avenida Antonio Dovalí Jaime No. 70, Mexico City, DF, Mexico, 01210

People

Directors & Officers

Name Title Year Born
Lic. Rodrigo Alonso Herrera Aspra Founder & Chairman of the Board NA
Mr. Juan Marco Sparvieri Chief Executive Officer NA
Engineer Antonio Zamora Galland Executive VP of Finance & Administration and CFO NA
Ms. Christianne Ibáñez Garcia Head of Investor Relations NA
Mr. Efraan Tapia Cardova Director of Legal & Secretary NA
Mr. Alejandro Bastón Patiño EVP of Institutional Relations, Media, HR & Sustainability NA
Daniel Suarez Neria Investor Relations Officer NA

Financial Highlights

Market Cap: $12.47B
EBITDA: $3.90B
P/E Ratio: $7.68
PEG Ratio: $0.86
Book Value: $12.08
Dividend/Share: $0.40
Dividend Yield: 3.09%
Earnings/Share: $1.66
Profit Margin: 9.56%
Operating Margin: 19.95%
ROA (TTM): 9.10%
ROE (TTM): 14.16%
Revenue (TTM): $17.05B
Revenue/Share (TTM): $17.40
Earnings Growth (YOY): 3.90%
Revenue Growth (YOY): -6.00%

Valuation Metrics

Enterprise Value: $17.96B
Trailing P/E: 7.68
Forward P/E: 6.37

Shares Statistics

Shares Outstanding: 977.75M
Shares Float: 672.56M
% Insiders: 31.05%
% Institutions: 33.62%

Stock Price History

1 Year Price History

3 Years Price History

10 Years Price History

Financial Charts

Revenue, Net Income & Operating Cash Flow (Yearly)

Revenue, Net Income & Operating Cash Flow (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$17.54B
Cost of Goods Sold
adjust
$-6.52B
Gross Profit
subtotal
$11.02B
SG&A
adjust
$-7.29B
Other Operating Expense
adjust
$-6.49B
Operating Income
subtotal
$3.76B
Other / Non-Operating Items
adjust
$-2.14B
Net Income
subtotal
$1.61B

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about LABB.MX!